In addition, EMT biomarkers CDH1 and VIM were highly expressed in cancer cells, consistent with previous reports showing that TAM promoted EMT progress of cancers (lung cancer, colorectal cancer, breast cancer and ovarian cancer) by SPP1[64]. This evidence concerns the gene VIM and colorectal cancer.